July 9, 2014
Lynda Dee of the Fair Pricing Coalition (FPC) spoke with coworkers Jeff Berry and Murray Penner, as well as David Evans of Project Inform, about access to HIV and hepatitis C (HCV) medications. FPC negotiates with pharmaceutical companies to make these drugs affordable for patients. Ongoing programs include a co-pay card that will cover medication co-payments and a patient assistance program for people without health insurance. In response to the Affordable Care Act (ACA), a third program is intended to cover coinsurance payments or deductibles for the ACA-sponsored Bronze plans. However, government agencies still disagree about whether such coverage will be permitted. Also mentioned was the fact that some HIV and HCV medications are not on insurance companies' lists of drugs they cover (so-called formularies). The panelists asked viewers to advocate with their local members of Congress around some of these issues.
Watch the video to learn more:
About the panelists:
The video above has been posted on TheBodyPRO.com with permission from our partners at the International Foundation for Alternative Research in AIDS (IFARA). Visit IFARA's website or YouTube channel to watch more video interviews from the conference, as well as earlier meetings.
Barbara Jungwirth is a freelance writer and translator based in New York.
Follow Barbara on Twitter: @reliabletran.
No comments have been made.
The content on this page is free of advertiser influence and was produced by our editorial team. See our content and advertising policies.
|A Review of Late-Stage HIV Antiretroviral Candidates at IDWeek 2017|
|PrEP Prescriptions Rise Sharply, but Unequally, in New York City|
|How to Reverse Implicit Bias in HIV Care: 6 Steps to Take Today|
|Free Your (and Carl's) Mind: An Open Letter to Anthony Fauci About HIV Prevention Research Priorities|
|This Week in HIV Research: Injectable PrEP Shows Promise in New Study|
|Better Use of Electronic Health Records Might Help Close HIV Testing Gap in U.S.|